| Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial | Lancet, The | 2019 | 1.3K |
| Notch signalling in solid tumours: a little bit of everything but not all the time | Nature Reviews Cancer | 2011 | 602 |
| Kaposi's sarcoma and its associated herpesvirus | Nature Reviews Cancer | 2010 | 559 |
| Resilience and Thriving: Issues, Models, and Linkages | Journal of Social Issues | 2010 | 462 |
| Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas | Nature Genetics | 2014 | 413 |
| 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo | Cancer Research | 2004 | 371 |
| Human viral oncogenesis: a cancer hallmarks analysis | Cell Host and Microbe | 2014 | 364 |
| Cancer prevention with natural compounds | Seminars in Oncology | 2010 | 350 |
| Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma | Journal of Clinical Oncology | 2008 | 336 |
| Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention | Ca-A Cancer Journal for Clinicians | 2017 | 303 |
| IRF7: activation, regulation, modification and function | Genes and Immunity | 2011 | 288 |
| A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors | Cancer Chemotherapy and Pharmacology | 2013 | 268 |
| EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3 | Cancer Research | 2008 | 261 |
| JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia | American Journal of Physiology - Endocrinology and Metabolism | 2012 | 250 |
| Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma | Blood | 2016 | 238 |
| STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia | PLoS ONE | 2011 | 237 |
| Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database | Journal of Bone and Joint Surgery - Series A | 2009 | 230 |
| Triple negative breast cancer: unmet medical needs | Breast Cancer Research and Treatment | 2011 | 226 |
| EGFR targeting of solid tumors | Cancer Control | 2007 | 220 |
| Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas | Blood | 2009 | 213 |
| Prognostic biomarkers in diffuse large B-cell lymphoma | Journal of Clinical Oncology | 2006 | 209 |
| Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients | Annals of Surgery | 2007 | 199 |
| A phase I weekly dosing study of brentuximab vedotin in patients with relapsed/refractory CD30-positive hematologic malignancies | Clinical Cancer Research | 2012 | 190 |
| Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic | JAMA Oncology | 2016 | 187 |
| Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer | International Journal of Molecular Sciences | 2017 | 176 |
